- Home
- EXTR vs DYN Comparison
EXTR vs DYN Comparison
Compare EXTR & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXTR | DYN |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EXTR | DYN |
|---|---|---|
| Price | $22.30 | $17.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 17 |
| Target Price | $33.63 | ★ $34.33 |
| AVG Volume (30 Days) | 1.4M | ★ 2.8M |
| Earning Date | 10-28-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 616.67 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $1,283,593,000.00 | N/A |
| Revenue This Year | $9.74 | N/A |
| Revenue Next Year | $9.69 | N/A |
| P/E Ratio | $185.58 | ★ N/A |
| Revenue Growth | ★ 12.59 | N/A |
| 52 Week Low | $13.48 | $14.00 |
| 52 Week High | $33.73 | $27.31 |
Technical Indicators
Market Signals| Indicator | EXTR | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 47.34 | 53.66 |
| Support Level | $21.56 | $16.65 |
| Resistance Level | $23.16 | $17.31 |
| Average True Range (ATR) | 1.04 | 0.86 |
| MACD | 0.04 | 0.38 |
| Stochastic Oscillator | 19.40 | 87.28 |
Price Performance
Historical ComparisonAbout EXTR Extreme Networks Inc.
Extreme Networks Inc is an AI-powered cloud-based networking company focused on delivering simple and secure solutions that enable connections among devices, applications, and users. The Company leverages artificial intelligence, analytics, and automation in its products and services, and designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. Its offerings include networking equipment, software subscriptions, related maintenance contracts and the Extreme Platform ONE solution. The Company operates in a single reportable segment focused on the development, marketing, and sale of network infrastructure equipment and related software and subscriptions. The Company generates maximum revenue from the United States.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.